# Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study

> **NCT00687791** · PHASE3 · UNKNOWN · sponsor: **Pro Top & Mediking Company Limited** · enrollment: 20 (estimated)

## Conditions studied

- Cataract
- Glaucoma

## Interventions

- **DEVICE:** ologen™ Collagen Matrix Implant as an aid in phacotrabeculectomy surgery

## Key facts

- **NCT ID:** NCT00687791
- **Lead sponsor:** Pro Top & Mediking Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-12
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687791, "Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00687791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*